Sign in

CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270604595
Phone
781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-31 Trachtenberg Eric SEE REMARKS Returned to the company · Stock Option (right to buy) −2,399 0
2023-05-31 Trachtenberg Eric SEE REMARKS Returned to the company · Stock Option (right to buy) −1,813 0
2023-05-31 Trachtenberg Eric SEE REMARKS Returned to the company · Stock Option (right to buy) −3,059 0
2023-05-31 Trachtenberg Eric SEE REMARKS Returned to the company · Stock Option (right to buy) −648 0
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Grant or award +14,736 26,619
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Returned to the company · Stock Option (right to buy) −1,841 0
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Returned to the company · Stock Option (right to buy) −578 0
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Returned to the company · Stock Option (right to buy) −1,399 0
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Returned to the company · Stock Option (right to buy) −2,999 0
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Returned to the company · Stock Option (right to buy) −2,399 0
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Returned to the company · Stock Option (right to buy) −1,813 0
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Returned to the company · Stock Option (right to buy) −3,059 0
2023-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Returned to the company · Stock Option (right to buy) −648 0
2023-05-31 Brazzell Romulus K SEE REMARKS Grant or award +17,916 36,452
2023-05-31 Brazzell Romulus K SEE REMARKS Returned to the company · Stock Option (right to buy) −308 0
2023-05-31 Brazzell Romulus K SEE REMARKS Returned to the company · Stock Option (right to buy) −2,047 0
2023-05-31 Brazzell Romulus K SEE REMARKS Returned to the company · Stock Option (right to buy) −942 0
2023-05-31 Brazzell Romulus K SEE REMARKS Returned to the company · Stock Option (right to buy) −1,399 0
2023-05-31 Brazzell Romulus K SEE REMARKS Returned to the company · Stock Option (right to buy) −2,999 0
2023-05-31 Brazzell Romulus K SEE REMARKS Returned to the company · Stock Option (right to buy) −2,399 0

Page 9 of 12 · 236 trades